Read + Share
Bryushkova EA, Skatova VD, Mutovina ZY, Zagrebneva AI, et al. Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate
COVID-19: An observational study. PLoS One 2022;17:e0273340.
PMID: 36001576
|
 |
|
Bryushkova EA, Skatova VD, Mutovina ZY, Zagrebneva AI, et al. Tocilizumab, netakimab, and baricitinib in patients with mild-to-moderate
COVID-19: An observational study. PLoS One 2022;17:e0273340.
PMID: 36001576
|
|
|
|